SMi Group reports: The 6th Annual Highly Potent Active Pharmaceutical Ingredients Conference is set to return in May 2022 with a focus on key regulatory updates, and leading case studies from leading pharmaceutical and biotechnology […]
Trial lawyers with the Lanier Law Firm have filed a $10 million lawsuit against Johnson & Johnson, its Janssen Pharmaceuticals subsidiary, and other parties on behalf of a New Hampshire woman who suffered eye damage […]
UCB has signed a definitive agreement to acquire rare diseases therapies developer Zogenix in a deal valued at about $1.9bn. Under the deal, the company will initiate a tender offer through its subsidiary Zinc Merger […]
Indian start-up LaBelforte has launched its special purpose business entities, Covidrops and Covinhaler, for facilitating immune optimising nasal and inhaled drug products development to treat Covid-19. The two entities will aid in the development of […]
Australia’s health minister has announced that Novavax’s Covid-19 vaccine will be rolled out across the country from February 21. The news comes just days after the Australian drugs regulator Therapeutic Goods Administration (TGA) provisionally approved […]